Thomas James Belbin currently works as an Associate Professor in the Discipline of Oncology, Memorial University of Newfoundland. His current research is focused on the analysis of DNA methylation in the genomes of head and neck cancer cells. These biomarkers can be used to identify sequences frequently methylated in tumor cells and to characterize previously indistinguishable subtypes of this disease. This should lead to more unique gene discoveries and, in the future, new targets for anti-tumor drugs.
Thomas James Belbin currently works as an Associate Professor in the Discipline of Oncology, Memorial University of Newfoundland. His current research is focused on the analysis of DNA methylation in the genomes of head and neck cancer cells. These biomarkers can be used to identify sequences frequently methylated in tumor cells and to characterize previously indistinguishable subtypes of this disease. This should lead to more unique gene discoveries and, in the future, new targets for anti-tumor drugs.